Home › Graves Disease › Ohio
Graves Disease clinical trials in Ohio
4 studies for Graves Disease are looking for participants at sites in Ohio.
Cities in Ohio
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-008, Canton
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 17, 2026 · NCT07661056A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1057, Canton
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1104, Columbus
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Aug 24, 2026 · NCT07305818Study of BHV-1300 in Graves' Disease
- Site-110, Canton
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.